Search - tctmd.com

Displaying 21 - 40 of 214

Sort: Relevancy | Date

Presentation THT 2025

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

Trials and Tribulations of Xeno-Transplant

Presenter: Albert Hicks

February 12, 2025

Presentation THT 2025

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Presenter: Thitiphan Srikulmontri

February 12, 2025

Presentation THT 2025

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Presenter: Neha Panigrahy

February 12, 2025

Presentation THT Abstracts 2025

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Presenter: Neha Panigrahy

February 11, 2025

Presentation THT Abstracts 2025

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Presenter: Jason Feinman

February 11, 2025

Presentation THT 2025

Robotic Surgical Technique for Performing Heart Transplant

Presenter: Feras Khaliel

February 11, 2025

Presentation THT 2025

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Presenter: Jason Feinman

February 11, 2025

Presentation THT 2025

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Presenter: Mazen Hanna

February 11, 2025

Presentation THT 2025

Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021)

Presenter: Viet Nghi Tran

February 11, 2025

News Conference News STS 2025

Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy

Yael L. Maxwell

January 30, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Palliative Care in HF: Practical Advice From the HFSA

Caitlin E. Cox

December 05, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

Presentation TCT 2024

TCT 965: Traditional Risk Factors Are Not Associated With the Development of Allograft Vasculopathy, but They Are Associated With More Severe Lesions Requiring Percutaneous Coronary Intervention

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

TCT 966: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Based on Coronary Angiography in Heart Transplanted Patients

Presenter: Simone Fezzi

October 28, 2024

Presentation TCT 2024

TCT 962: HF-OCT and CMD Evaluation for Cardiac Allograft Vasculopathy: The Chicken or the Egg?

Presenter: Donald Quimby Jr

October 28, 2024

Advertisement

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Trials and Tribulations of Xeno-Transplant

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Robotic Surgical Technique for Performing Heart Transplant

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021)

Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Palliative Care in HF: Practical Advice From the HFSA

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

TCT 965: Traditional Risk Factors Are Not Associated With the Development of Allograft Vasculopathy, but They Are Associated With More Severe Lesions Requiring Percutaneous Coronary Intervention

TCT 966: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Based on Coronary Angiography in Heart Transplanted Patients

TCT 962: HF-OCT and CMD Evaluation for Cardiac Allograft Vasculopathy: The Chicken or the Egg?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content